期刊文献+

白念珠菌耐药机制的研究进展 被引量:2

Advances in research on mechanisms for drug resistance of Candida albicans
下载PDF
导出
摘要 近年来白念珠菌感染发病率剧增,随着抗真菌药物的广泛使用,耐药菌株不断出现,耐药现象已经成为药物治疗的严峻挑战。目前已经明确的耐药机制包括:膜转运蛋白的过度表达,药物作用靶酶基因过度表达或突变,甾醇合成通路中其他酶的改变,生物被膜的形成,小囊状空泡的影响等。本文对白念珠菌的耐药机制做一综述。 The incidence of candidiasis caused by Candida albicans has increased dramatically in recent years. With the widespread use of antifungal agents, the emergence of drug resistant strains poses a major challenge to drug treatment. Multiple definite molecular mechanisms contribute to the development of resistance in Candida albicans, including overexpression of genes coding membrane transport proteins, increased expression and mutations in the drug target enzymes, alterations of other enzymes in sterol biosynthesis pathway,formation of biofilm, the effect of vesicular vacuoles, etc. Here the resistant mechanisms in Candida albican are reviewed in this article.
出处 《药学服务与研究》 CAS CSCD 2009年第3期171-174,共4页 Pharmaceutical Care and Research
关键词 念珠菌 白色 抗药性 真菌 多药耐药蛋白 综述 Candida albicans drug resistance, fungal multidrug resistance protein review
  • 相关文献

参考文献36

  • 1Lee I,Fishman NO,Lautenbach E,et al.Risk factors for fluconazole-resistant Candida glabrata bloodstream infection[J].Arch Intern Med,2009,169(4):379-383.
  • 2Lockhart S R,Messer S A,Diekema D J,et al.Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates:comparison to the literature[J].J Clin Microbiol,2009,47(4):1216-1217.
  • 3Chiou C C.New drugs and novel targets for treatment of invasive fungal infections in patients with cancer[J].Onco-logist,2000,5(2):120-135.
  • 4White T C,Holleman S,Dy F,et al.Resistance mechanisms in clinical isolates of Candida albicans[J].Antimicrob Agents Chemother,2002,46(6):1704-1713.
  • 5Georgiev V S.Membrane transporters and antifungal drug resistance[J].Curr Drug Target,2000,1(3):261-284.
  • 6Wirsching S,Michel S,Kohler G,et al.Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant,clinical Candida albicans strains is caused by mutations in a trans-regulatoy factor[J].J Bacteriol,2000,182(2):400-404.
  • 7Benedicte R,Zuzana K,Dominique S,et al.Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans,a major facilitator transporter involved in azole resistance[J].Microbiology,2006,152:3701-3722.
  • 8Morschhauser J,Barker K S,Homayouni R,et al.The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans[J].PLoS Pathog,2007,3(11):1603-1616.
  • 9Alarco A M,Raymond M.The bZip transcription factor cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans[J].J Bacteriol,1999,181(3):700-708.
  • 10Hiller D,Sanglard D,Morschha J.Overexpression of the MDR1 gene is sufficient to confer increased resistance to toxic compounds in Candida albicans[J].Antimicrob Agents Chemother,2006,50(4):1365-1371.

同被引文献14

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部